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Aim. To gain insight into structural and functional properties of alanyl-tRNA,synthetase 
(AlaRS), we genetically engineered constructs for expression and purification of full-length 
AlaRS and checked its activity in aminoacylation assays. Methods. The genomic DNA for 
the AlaS gene from the T. thermophilus (HB 27 strain) was amplified by PCR and cloned into 
vectors with and without a histidine tag. To optimize conditions for the protein expression in 
E.coli and to develop efficient purification procedure, the molecular biology techniques were 
applied. AlaRS was purified by affinity and size-exclusion chromatography. The molecular 
weight of enzyme was determined by gel filtration. Results. The expression and purification 
conditions for recombinant AlaRS were optimized. Approximately 1.5 mg of the pure active 
recombinant enzyme can be obtained from 1 L of bacterial culture. AlaRS from T. thermophi-
lus is a dimer in solution with an experimental MW of 204 kDa. Conclusions. The purified 
recombinant enzyme will be used for further studies on the functional kinetics and structure 
of the crystal complex with tRNA.
K e y w o r d s: aminoacyl-tRNA-synthetase, AlaRS from T. thermophilus, expression of re-
combinant protein, protein purification.
Introduction
Aminoacyl-tRNA-synthetases (aaRSs) attach 
cognate amino acids (aa) to their tRNAs in a 
two-step reaction: 1) the activation of amino acid 
with ATP (generation of aa-AMP) and 2) the 
transfer of activated amino acid to the 3’-end of 
tRNA (formation of aminoacyl-tRNA) [1, 2]. 
By different functional and structural features, 
these enzymes were divided into classes I and 
II [3–5]. Alanyl-tRNA synthetase (AlaRS) be-
longs to class II and consists of four domains: 
the N-terminal (aminoacyl ation domain), editing 
one, the domain of tRNA recognition and the 
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C-terminal domain, responsible for oligomeriza-
tion [6]. The C-Ala domain also has a subdo-
main, which plays an essential role in aminoac-
ylation and editing [7]. In different organisms, 
AlaRS may have a quaternary structure of tet-
ramer (Escherichia coli) [8] or dimer (Thermus 
thermophilus HB8) [9], or exist as a monomer 
(Bombyx mori) [10]. Noteworthy, this synthetase 
has a special history of study: on the one hand, 
AlaRS from E. coli is the first synthetase that 
was cloned, sequenced [11], characterized ge-
netically [12] and biochemically [13, 14], on the 
other hand, only after 25 years of research the 
first crystal structure of AlaRS was resolved for 
the 453-aa N-terminal catalytic fragment of the 
Aquifex aeolicus enzyme [15]. Then the 441-aa 
catalytic fragment of E.coli AlaRS with different 
leucine-zipper surface mutations in the complex 
with glycine, L-alanine and L-serine was re-
ported [16]. Later the modified leucine half-
zipper technique [17] was used for the E.coli 
AlaRS and the interactions between tRNAAla 
and the synthetase were studied by ITC 
(Isothermal Titration Calorimetry) [18]. 
The alanyl-system is also interesting in its 
recognition context. tRNAAla contains a unique 
wobble G3:U70 base pair in the acceptor stem 
which determines its specificity to AlaRS [19]. 
Recently, the first complex of archaeon AlaRS 
catalytic fragment from Archaeoglobus ful-
gidus has been reported in 2 states — with 
tRNAAla bearing G3·U70 and with variant 
A3·U70 [20]. Interestingly, human AlaRS was 
identified to be able to mischarge G4:U69-
tRNA, possessing an evolutionary gain-of-
function and not being an accidental mistake 
[21]. The human C-Ala domain evolutionarily 
lost its prokaryotic tRNA functional role [7] 
on editing and aminoacylation and is remol ded 
into the DNA-binding protein [22]. Recently, 
Chong et al. have reported three different strat-
egies in the G3:U70 recognition among king-
doms of life [23]. On the other hand, it was 
shown for E.coli AlaRS that G3:U70 pair is an 
important element for specific interaction with 
the editing domain of the enzyme [19]. Thus, 
the precise recognition mechanism abides dis-
putable until the spatial structure of full-length 
AlaRS with tRNAAla is solved. 
Despite the progress in the field, the mech-
anisms of aminoacylation and editing by AlaRS 
remain unknown; the observations of func-
tional and structural properties of synthetases 
from all kingdoms of life are still relevant. In 
this study we cloned AlaRS from the T. ther-
mophilus HB27 strain (AlaRSTT), developed 
and compared purification technique of enzyme 
with and without C-terminal 6-histidine-tag, 
resulted in a fast 2-step purification procedure. 
Materials and Methods
Cloning of alaS gene. Genomic DNA from T. 
thermophilus cells was obtained according to 
[24]. Based on the sequence information of 
alaS from Thermus thermophilus strain HB27 
(P61707 in UniProt [25] and WP_011173855.1 
in GenBank [26], 882 amino acid residues) a 
pair of primers was designed for PCR: 5’ for-
ward – atatgcgcacggcggagatccgcgagaagttcc 
and 5’ reverse – aagcttattaggggaggaggcc-
ggggagggcctcccgg, which contained NdeI and 
HindIII restriction sites (marked respectively). 
Long-PCR-mix (Pfu+Taq) was used for gene 
amplification. PCR product was gel purified 
and further cloning proceeded according to 
TOPO TA protocol («Invitrogen», USA) into 
the pCR2.1 vector. Briefly, 6 µl of mixture, 
consisted of 2/3 volume of purified PCR pro-
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duct, 1/6 — pCR2.1 vector, 1/6 — salt solution 
(200 mM NaCl, 10 mM MgCl2), was incu-
bated at 37ºC for 10 min. Electrocompetent 
Top10 E.coli cells («Invitrogen», USA) were 
used for the transformation («Bio-Rad» elec-
troporation system). The blue-white screening 
was performed for selection of KanR and AmpR 
clones with further restriction analysis for 
target gene (about 2646bp) detection. Positive 
clones were confirmed by NcoI and HindIII 
restriction and visualized on 1.5 % agarose gel. 
The correct sequence of AlaRSTT gene was 
confirmed by DNA sequencing.
To create the His-tagged protein construc-
tion, C-terminal linker, encoding 6 histidine 
residues, was added in PCR with 2 primers: 
5’-ctccccggcctcctcccctataagcttgcggccgcac tcg-3’ 
(AlaRSTT-6His-1) and 5’-cgagtgcggccgcaagct-
tataggggaggaggccggggag-3’ (AlaRSTT-6His-2). 
Then both AlaRSTT constructions (with and 
without His-tag) were excited by NcoI and 
Hind III Fast Digest («Thermo Scientific») 
restrictases and ligated into the pET28b vector, 
previously dephosphorylated by 1 unit of 
shrimp phosphatase in 1X reaction buffer 
(«Roche»). Ligation proceeded with 1 unit of 
T4-DNA-ligase in 1X ligase buffer («Thermo 
Scientific») for 20 h at 14ºC, followed by 
Top10 electroporation and sequencing. 
A small-scale test of AlaRSTT expression
The E.coli BL21(DE3)Star cells were electropor-
ated with pET28b-AlaRS/His-AlaRS plasmid. 
The analysis of the expression level was per-
formed in P (phosphate), LB (Lauria-Broth) and 
TB (Terrific-Broth), supplemented with kanamy-
cin (50 µg/ml). Pre-culture (2 ml) was grown 
overnight at 37 °C. Culture (10 ml of each me-
dium) was inoculated by pre-culture in 1:100 
dilution, at OD600 = 0.6 the protein expression 
was induced by 1 mM IPTG for 3 h. Cells were 
harvested by centrifugation (10 min, 6000 × g at 
4 °C) and resuspended in 50 mM Tris-HCl, pH 
8.0, 5 mM EDTA, 4 % gly ce rol, 20 mM 
β-mercaptoethanol, 1X cocktail of protease in-
hibitors («Roche»), 0.5 μg/μl lysozyme, followed 
by 2 cycles of freezing/defros ting (80 °C, 
10 min). To reduce the viscosity, 25 mM MgCl2 
and 1 u/μl DNase I were added and left for 
15 min at 37 °C. The lysed cells were centrifuged 
for 30 min at 6000 × g. The supernatant (fraction 
of soluble proteins) was analysed by 10 % PAGE.
Expression of AlaRSTT and strategy 
of its purification 
Pre-culture (50ml) of E.coli BL21(DE3)Star, 
carrying pET28b-AlaRSTT plasmid, was 
grown in LB with kanamycin (50 µg/ml) over-
night at 37 °C. The cell culture (1 L) was in-
oculated with pre-culture and grown to 
OD600 = 0.6; after the induction of protein 
expression with 1 mM IPTG, the culture was 
grown for 3 hours at 37 °C. 
All subsequent steps were conducted at 
4 °C. Cells were precipitated at 15 000 x g for 
20 min. The precipitate was resuspended in a 
buffer A (20 mM Tris-HCl pH 8.0, 5 mM DTT, 
0.1 mM EDTA, 1 mM PMSF, a tablet of a 
cocktail of protease inhibitors («Roche»)). 
Lysozyme was added for better cell lysis (to a 
final concentration of 1 mg/ml) and incubated 
for 30 min. Cells were disrupted by sonication 
8 × 30 sec with 1 min breaks. The lysate was 
heated at 70 °C for 35 min, debris was pre-
cipitated by centrifugation at 20 000 × g 
(30 min). The resulting supernatant was ap-
plied to a DEAE-Sepharose column (30 ml, 
«GE Healthcare»), pre-equilibrated with mo-
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di fied buffer A (0.1 mM PMSF and 0.1 mM 
EDTA) and further washed with it. AlaRSTT 
was eluted in the linear gradient concentration 
of NaCl – from 0 to 350 mM. Collected frac-
tions were analysed by Bradford assay and 
SDS-PAGE. Fractions containing protein were 
combined and desalted to the 90 % concentra-
tion of (NH4)2SO4 (600 g/L). The precipitate 
was dissolved in a buffer B (50mM Tris-HCl 
pH 8.0, 150mM NaCl, 0.003 % NaN3,) and 
applied to the pre-equilibrated Hi-Load 16/60 
Superdex 200 (150 ml, «Pharmacia Biotech») 
column with flow rate 0.5 ml/min. The iso-
lated fractions were concentrated on 10 kDa 
Centricon («Merck») at 6000 rpm, analysed 
spectrophotometrically and electrophoreti-
cally, their aminoacylation activity was deter-
mined before freezing and storage at -20 °C.
Final protein concentrations were deter-
mined by the Bradford assay using Roti®-Quant 
(«Roth») [27]. Light absorption coefficient at 
280 nm (ε280 = 93530 M-1 cm-1) and absorbance 
of 0.1 % solution (A280 (1 mg/ml) = 0.959 
unites·mg-1·ml) were calculated from the ami-
no acid sequence of the DTDTT (ProtParam 
tool, ExPASy, Swiss Port) [28] and used for 
determination of enzyme concentration.
His-AlaRSTT purification by affinity and 
size-exclusion chromatography
The production of His-tagged recombinant pro-
tein was performed with 0.6 mM IPTG induc-
tion during 3 hours at 37 °C in P-medium (1 L). 
All steps of His-AlaRSTT purification were 
performed at 4°C. Harvested cells after 30 min 
centrifugation (15 000 x g) were resuspended 
in buffer C (50 mM Tris-HCl pH 8.0, 300 mM 
NaCl, 1 mM β-mercaptoethanol, 1X protease 
inhibitors cocktail («Roche»)), sonicated 
10 × 30 sec with 1 min breaks. Then cell debris 
was precipitated (20 000 × g, 30 min), heated 
in water bath (70°C), and followed by centrifu-
gation. The concentration of imidazole 
(«Sigma») was adjusted to 15 mM and the clear 
supernatant was added to Ni-NTA Sepharose 
Fast Flow resin (2 ml of 50 % slurry, «GE 
Healthcare»), pre-equilibrated with the same 
buffer and incubated for 1 h at 150 rpm. The 
resin was washed with buffer C, supplemented 
with 15 mM imidazole followed by washing 
with solution containing 500 mM NaCl. 
AlaRSTT was eluted from the column by 
250 mM imidazole (as E.coli enzyme [17]). 
Target protein fractions were combined and 
dialyzed overnight against 1 L of buffer D 
(50 mM Tris-HCl pH 8.0, 5 mM MgCl2 (as 
recommended for Archaeoglobus fulgidus 
AlaRS [29]), 1 mM β-mercaptoethanol), con-
centrated on 30 kDa Centricon at 6000 rpm to 
1 ml volume (4 mg/ml) and loaded to the Hi-
Load 16/60 Superdex 200 column, pre-equi lib-
rated with buffer D, supplemented with 
150 mM NaCl, 0.1 mM PMSF, 0.003 % NaN3) 
with flow rate 1 ml/min. Peak fraction was 
concentrated on 30 kDa Centricon (before con-
centration this fraction was 3-fold diluted in 
1 mM β-mercaptoethanol and a saturated solu-
tion of (NH4)2SO4 in proportion 1:20), the pu-
rity was analysed by SDS-PAGE.
Gel filtration of proteins
To access the approximate molecular weight of 
purified AlaRSTT the size-exclusion chroma-
tography on Hi-Load 16/60 Superdex S 200 was 
performed. The column was equilibrated with 
50 mM Tris-HCl pH 8.0, 5 mM MgCl2 1 mM 
β-mercaptoethanol, 150 mM NaCl, 0.1 mM 
PMSF, 0.003 % NaN3. All samples ran at 1 ml/
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min flow rate, the elution was monitored at 
280 nm. An elution volume of each protein 
sample from the column was calculated; the log 
(MW) of marker proteins  was plotted against 
the ratio Ve / Vo. Marker proteins, which were 
used for column calibration, are the following: 
ferritin dimer (900 kDa), ferritin monomer (450 
kDa), β-amilase (200 kDa), alcohol dehydroge-
nase (150 kDa), bovine serum albumin (66 kDa), 
ovalbumin (45 kDa), carboanhydrase (29 kDa) 
and cytochrome c (12,4 kDa). The molecular 
weight of AlaRSTT was determined by com-
parison of its Ve / Vo index with those of known 
protein standards. The calibration curve is 
shown in Fig. 5.
Test of the aminoacylation activity 
of purified AlaRSs
The reaction mixture (25 µl) contained 100 mM 
Tris-HCl pH 7.5, 15 mM MgCl2, 100 µg/ml 
BSA, 3 mM ATP, 25 µM [14C]-L-Ala (158 mCi/
mmol; Amersham), 5 µg/µl total tRNA, 50 nM 
AlaRS was conducted at 37 °C for several 
minutes. Aliquots were removed from the reac-
tion at appropriate time points, quenched by 
cold 10 % TCA and passed through nitrocel-
lulose filters. Dried filters were analysed by 
liquid scintillation counting. 
Results and Discussion
Expression and purification of the full-
length AlaRSTT with problem of its 
proteolysis 
The final protein expression was performed 
successfully in the LB medium (Fig. 1). Even 
at the expression step and analysis of protein 
solubility, we noticed rapid protein degrada-
tion, which did not show the dependence on 
media or buffer composition (Fig.1, 1 — full-
length protein, 2a/b — proteolyzed). 
The purification procedure combined the 
anion exhange and size-exclusion chromatog-
raphies. The peak fractions, eluted from DEAE-
Sepharose with the linear gradient of NaCl 
(0-350 mM), were desalted by (NH4)2SO4 and 
uploaded on Superdex 200 column (Fig. 2). 
During both purification steps, the ratio of full-
length and proteolyzed forms of AlaRSTT re-
mained constant. Despite the including of pro-
teases inhibitors in all solutions, it was impos-
sible to reduce the level of synthetase degrada-
tion. We hypothesize that a short form appeared 
due to the existence of unstable regions of the 
protein C-terminal domain, which led to the 
damage and shortening of the target enzyme. 
This issue seems to be the main reason 
AlaRSTT has not been crystalized yet, despite 
the first report of its purification  from  the 
Fig. 1. Test of AlaRSTT expression in LB, TB and P-me-
dia after 3h of induction with 1 mM IPTG (soluble frac-
tion). M –marker (ThermoFisher, PageRulerTM Prestained 
Protein ladder 10-170 kDa).
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T. thermophilus strain HB8 more than 20 years 
ago [9]. There is no evidence how to overcome 
this problem, therefore our work is relevant. 
Expression and purification of the full-
length AlaRSTT with C-terminal His-tag
To overcome the problem with AlaRSTT deg-
radation, we recloned it with C-terminal His-
tag. Surprisingly, it increased the protein stabi-
li ty up to 90 %. At the first purification step 
(affinity chromatography on Ni-NTA-
Sepharose), only about 5-10 % of degraded 
AlaRSTT were observed (Fig. 3). We tried to 
elute AlaRS with the imidazole gradient, var-
ied concentrations of NaCl and β-mercapto-
ethanol in lysis buffer, adding one more puri-
fication step after affinity column (DEAE-
Sepharose), but it did not help to eliminate the 
Fig. 2. Purification of AlaRSTT without His-tag by anion exhange and size-exclusion chromatographies. 12.5 % SDS-
PAGE: 1 — lysate after heating; 2 — protein mar ker (BioRad LowRange); 3 — 23rd fraction on DEAE-Sepharose; 
4–7 — peak fractions (24–27 respectively) on DEAE-Sepharose, combined for desalting; M — molecular weight 
marker (ThermoFisher, PageRulerTM Prestained Protein ladder 10–170 kDa); 8–9 — concentra ted AlaRSTT fractions 
(8-full-length, 9-short) after Superdex 200 column.
Fig. 3. Two-step purification procedure of His-AlaRSTT: 1 — lysate, uploaded to Ni-NTA-Sepharose column; 2 — 
fraction of proteins, not bound with Ni-NTA; 3 — wash flow-through fraction; 4–9 — peak fractions, eluted from co-
lumn; K — control, LeuRS from Mycobacterium tuberculosis (107 kDa); 10 — combined eluate after dialysis, loaded 
on Superdex 200 column, 11–17 — fractions on gel-filtration column (1–7 respectively).
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primary (about 10 %) protein degradation 
level (data not shown). Nevertheless, the ratio 
did not increase after overnight dia lysis and 
the second (size-exclusion) chromatography 
step (Fig. 4). The elution profile of AlaRSTT 
on the gel-filtration column is represented in 
Fig. 4 (A — construct without His, B — with 
C-terminal 6xHis-tag). The Fig. 4B profile 
together with the elution of marker proteins 
were used for the determination of AlaRSTT 
molecular weight (MW). The theoretically 
calculated MW of the corresponding monomer 
structure was 97.48 kDa. Experimentally, it 
was determined as 204.2 kDa, confirming 
protein dimeric form. Calibration curve is 
shown in Fig. 5. The total amount of purified 
protein was ~1.5 mg from 1L of bacterial 
culture (~4.2 g of cell pellet). Thus, our results 
are comparable with the lite rature data 
(Table 1).
Fig. 4. Purification of AlaRSTT on size-exclusion chromatography on Superdex S 200 column: A — Elution profile 
for AlaRSTT with flow rate 0.5 ml/min (1 — full-length protein, 2 — its shorten form); B — for 6xHis-AlaRSTT with 
flow rate 1 ml/min. 
Table 1. Comparison of purification steps and total enzyme quantities in T. thermophilus HB8 and HB27 strains
Total number of purification steps Purified protein amount from 1g of E.coli cells (mg)
His-tagged AlaRSTT (strain 
HB8)a 4 0.46
AlaRSTT (HB27)b 2
0.72 
(0.24 – full-length;
0.48 – short form)
His-tagged AlaRSTT (HB27)b 2 0.36
a Literature data, assumed from [9].
b Current study 
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Aminoacylation activity of purified 
AlaRSTT
All purified enzymes were tested for their 
activity with bulk tRNA from E.coli and ra-
diolabelled [14C]-L-Ala (Fig. 6). Noteworthy, 
the shortened form of AlaRSTT had only a 
2-fold less initial velocity in comparison to the 
full-length protein. Thus, aminoacylation do-
main of AlaRS (C-Ala) worked properly. The 
full-length AlaRS has a slightly higher veloc-
ity, so it will be used for further functional 
investigations.
Conclusions
The recombinant His-AlaRSTT was expressed 
in E.coli and purified to homogeneity without 
premixes of degraded forms. For the success-
ful expression and the prevention of protein 
degradation during purification steps, the af-
finity tag was attached to the C-end of the 
target enzyme. AlaRSTT will be used for fur-
ther structural studies and investigation of its 
editing mechanism.
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Експресія та очистка повнорозмірної аланіл-
тРНК-синтетази Thermus thermophilus штаму 
HB27
М. Ю. Рибак, А. Є. Пріcс, О. І. Гудзера, 
А. О. Ковальчук, І. А. Крикливий, М. А. Тукало
Мета. Для детального вивчення структурних та функ-
ціональних властивостей аланіл-тРНК-синтетази 
(АлаРС) було створено генно-інженерну конструкцію 
для експресії та очищення повнорозмірної синтетази 
та перевірено її активність у реакції аміноацилювання. 
Методи. Ген AlaS з T. thermophilus (штам HB27) ге-
номної ДНК ампліфікували за допомогою ПЛР з від-
повідними праймерами та клонували у вектор з та без 
гістидинової послідовності. Для оптимізації умов екс-
пресії білка в E.coli та розробки ефективної процедури 
очищення були застосовані сучасні методи молекуляр-
ної біології. AлаРС очищали методами афінної хрома-
тографії та гель-фільтрації. Молекулярна маса фермен-
ту визначалася на гель-фільтраційній колонці. 
Результати. Умови експресії та очистки рекомбінант-
ної АлаРС були оптимізовані. Близько 1,5 мг чистого 
рекомбінантного активного ферменту можна одержати 
з 1 л бактеріальної культури. АлаРС з T. thermophilus 
є димером у розчині з експериментальною масою 204 
кДа. Висновки. Отриманий рекомбінантний фермент 
буде використовуватися для подальших експериментів 
з функціональної кінетики та структурних досліджень 
кристалічного комплексу з тРНК.
К л юч о в і  с л о в а: аміноацил-тРНК-синтетаза, 
AлаРС T. thermophilus,  експресія рекомбінантного 
білка, хроматографічне очищення білка.
Экспрессия и очистка полноразмерной аланил-
тРНК-синтетазы Thermus thermophilus 
штамма HB27
М. Ю. Рыбак, А. Е. Присс, О. И. Гудзера, 
А. А. Ковальчук, И. А. Крикливый, М. А. Тукало
Цель. Для детального изучения структурных и функ-
циональных свойств аланил-тРНК-синтетазы (АлаРС) 
было создано генно-инженерную конструкцию для 
экспрессии и очистки полноразмерной синтетазы и 
проверено ее активность в реакции аминоацилирова-
ния. Методы. Ген аlaS из геномной ДНК T. thermophilus 
(штамм HB27) амплифицировали с помощью ПЦР с 
соответствующими праймерами и клонировали в век-
тор с и без гистидиновой последовательностью. Для 
оптимизации условий экспрессии белка в E.coli и 
разработки эффективной процедуры очистки были 
применены современные методы молекулярной био-
логии. AлаРС очищали методами аффинной хромато-
графии и гель-фильтрации. Молекулярная масса фер-
мента определялась на гель-фильтрационной колонке. 
Результаты. Условия экспрессии и очистки рекомби-
нантной АлаРС были оптимизированы. Около 1,5 мг 
чистого рекомбинантного активного фермента можно 
получить с 1 л бактериальной культуры. АлаРС с 
T. thermophilus является димером в растворе с экспе-
риментальной массой 204 кДа. Выводы. Полученный 
рекомбинантный фермент будет использован для даль-
нейших экспериментов с функциональной кинетики 
и структурных исследований кристаллического ком-
плекса с тРНК.
К л юч е в ы е  с л ов а: аминоацил-тРНК-синтетазы, 
AлаРС T. thermophilus, экспрессия рекомбинантного 
белка, хроматографическое очистки белка.
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